Stein M B, Uhde T W
Unit on Anxiety and Affective Disorders, National Institute of Mental Health, Bethesda, Maryland.
Psychiatr Clin North Am. 1988 Jun;11(2):441-61.
Considerable research has been conducted to clarify relationships between panic disorder and major depression. From a number of perspectives, it now appears that panic disorder and major depression are not identical illnesses. While many patients with panic disorder are likely to experience an episode of major depression at some point during their lives, the timing of this occurrence is highly variable. While depression may be an expected and understandable result of having to live with chronic anxiety and phobic avoidance, the available evidence suggests that such a hypothesis is not particularly tenable. Depression can occur in individuals with or without severe agoraphobia and in individuals ill with panic for greater or lesser periods of time. Comorbidity in panic, particularly for social phobic or obsessive-compulsive symptomatology, does serve as a risk factor for the lifetime occurrence of depression and may denote a more severe illness. Biologic markers (Table 4), while of limited diagnostic utility in clinical practice, may reveal important pathophysiologic similarities and differences between panic disorder and major depression. Current evidence points to many areas of biologic overlap, with some important areas of independence (Fig. 7A). Although not extensively discussed in this chapter, several clinical parameters paint an analogous picture (Fig. 7B). There is a need for future studies of biologic markers in individuals over time, in various phases of illness. Furthermore, the study of multiple biologic markers in the same individuals would be a worthwhile pursuit, perhaps leading toward the delineation of underlying pathophysiologic mechanisms. In summary, then, we favor a conceptualization of panic disorder and major depression as nonidentical disorders with many shared characteristics. Future studies as suggested above, particularly when coupled with the power of genetic studies not described in this chapter, may eventually lead to a clearer demarcation of the boundaries between these two intriguing psychiatric syndromes.
为了阐明惊恐障碍与重度抑郁症之间的关系,已经开展了大量研究。从多个角度来看,目前似乎惊恐障碍和重度抑郁症并非同一种疾病。虽然许多惊恐障碍患者在其一生中的某个时刻可能会经历一次重度抑郁发作,但其发生时间高度可变。虽然抑郁症可能是长期焦虑和恐惧回避生活的一种预期且可理解的结果,但现有证据表明这一假设不太站得住脚。抑郁症可发生在有或没有严重广场恐惧症的个体中,也可发生在患有惊恐障碍时间长短不一的个体中。惊恐障碍中的共病,特别是社交恐惧症或强迫症症状,确实是一生中发生抑郁症的危险因素,可能意味着病情更严重。生物标志物(表4)虽然在临床实践中的诊断效用有限,但可能揭示惊恐障碍和重度抑郁症之间重要的病理生理异同。目前的证据指向许多生物重叠领域,也有一些重要的独立领域(图7A)。虽然本章未广泛讨论,但一些临床参数也呈现出类似的情况(图7B)。需要对个体在疾病的不同阶段进行生物标志物的长期研究。此外,对同一患者的多种生物标志物进行研究将是一项有价值的探索,可能有助于描绘潜在的病理生理机制。总之,我们倾向于将惊恐障碍和重度抑郁症概念化为具有许多共同特征的不同疾病。上述未来研究,特别是与本章未描述的基因研究相结合时,最终可能会更清晰地界定这两种有趣的精神综合征之间的界限。